BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2018
View Archived Issues
Patient enrollment ongoing in first-in-human trial of PF-06939926
Read More
Sun Biopharma initiates first-line combination study of SBP-101 with gemcitabine and nab-paclitaxel
Read More
FDA gives fast track status to Ensysce's PF-614
Read More
Zika virus vaccine candidate from Takeda obtains FDA fast track designation
Read More
Trial results support safety and activity of carotuximab + sorafenib in hepatocellular carcinoma
Read More
ASPH marker possibly useful for CRC screening
Read More
EMA committee recommends approval of Lamzede for alpha-mannosidosis
Read More
United Neuroscience to develop vaccine to prevent chronic traumatic encephalopathy
Read More
GSK-2256098/trametinib combination lacks activity in phase II PDAC study
Read More
Innate Pharma and MedImmune collaborate to study IPH-5401 with durvalumab
Read More
Chinese authorities approve clinical trials of ZKAB-001
Read More
First patient with DLBCL enrolled in phase II study of Cellectar's CLR-131
Read More
FDA awards RMAT designation to Abeona Therapeutics' EB-101
Read More
Regeneron studies long-term safety and efficacy of evinacumab in patients with HoFH
Read More
BL-8040 therapy impacts immune cell populations in pancreatic cancer patients
Read More
FDA issues complete response letter for Linhaliq NDA
Read More
Pfizer files for approval of lorlatinib in Japan
Read More
Bristol-Myers Squibb presents novel ROCK inhibitors
Read More
Leo Pharma divulges RORG ligands for psoriasis
Read More
Almac Discovery discloses new Wee1 inhibitors
Read More
Duke University patents APC-containing vaccines for cancer
Read More
Ibentrus identifies new fusion proteins for cancer
Read More
ProMetic Life Sciences finalizes design of phase III study of PBI-4050 in IPF
Read More
FDA accepts revefenacin NDA
Read More
Johnson & Johnson reviews pipeline progress of fourth quarter 2017
Read More
Phase I data presented for JCAR-017 in B-NHL
Read More